Management decisions in subclinical thyroid disease.
Subclinical hypo- and hyperthyroidism are common, well-defined conditions that often progress to overt disease. In addition, there have been concerns that the subclinical states may contribute to hyperlipidemia, cardiac dysfunction, and osteoporosis. The author discusses the issues and outlines a rational approach to management that identifies patients who will benefit from treatment.
Hart
I R
IR
University of Ottawa.
D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000175:diagnosis / Q000503:physiopathology* / Q000628:therapy; D007037:Hypothyroidism / Q000175:diagnosis / Q000503:physiopathology* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D013972:Thyrotropin / Q000097:blood / Q000502:physiology; D013974:Thyroxine / Q000627:therapeutic use
D013972:Thyrotropin; D013974:Thyroxine